Sesame Care Review: $59 a Month, and None of It Is Medication

For the care, $99 a month if you stay month to month, or $59 a month if you commit and pay for twelve months up front. For the medication, a separate bill entirely: $349 a month for Wegovy through NovoCare once the two-month introductory rate ends, or $299 to $449 for Zepbound vials through LillyDirect depending on your dose. So the number that matters is the sum — $448 a month for semaglutide, $548 for tirzepatide at a maintenance dose. Read off sesamecare.com on August 9, 2026 and confirmed against the plan records inside Sesame's own booking code.

Two reasons, and they compound. The first is that it is an annual prepay divided by twelve — Sesame footnotes it on the landing page as "*Based on a 12-month Success by Sesame commitment", and its own FAQ lets you check the arithmetic: the annual plan saves "$480 per year compared to the monthly plan", and $99 × 12 − $480 = $708, which is $59 a month exactly. The division is baked into the software rather than the marketing; the plan records inside Sesame's booking bundle carry a `costDivisor` of 3, 6 or 12, and the code that picks the label prints "mo." whenever one is applied. The second reason is larger: neither $59 nor $99 buys any medication.

Clinical care, and Sesame is unambiguous about it. Its FAQ says: "The $99 subscription fee does not include the cost of medication." What you get is a video consultation with a provider you choose yourself, ongoing follow-ups, unlimited messaging with that same provider, lab orders and the cost of the labs in most states, help with insurance prior-authorisation paperwork, and a prescription if one is appropriate. That is a genuinely useful bundle and it is priced honestly against what it is. It is only misleading when a $59 badge sits in a buy card on a page about Zepbound, which is where most readers will meet it.

From the manufacturer, and no. For semaglutide, your Sesame provider sends the prescription to NovoCare, Novo Nordisk's own self-pay pharmacy; for tirzepatide, to LillyDirect, Eli Lilly's. You pay that pharmacy directly at the manufacturer's published cash price, and Sesame takes nothing from it. This is the best thing about the arrangement and it is worth being clear about: the drug half of your bill is the cheapest legitimate branded price available to a self-pay patient, and it is identical whether you reach it through Sesame or on your own. What Sesame charges for is the prescriber and the ongoing care that gets you there.

Because the subscription does not bill monthly. Sesame's "When will I be billed?" FAQ says "Month-to-Month Plan: Billed every 28 days", and its own software agrees twice — the function that describes the billing period returns "4 weeks" for the month-to-month weight-loss plans, and the subscription card string reads "Billed every 4 weeks". Twenty-eight days means thirteen charges a year: $1,287 of programme fee rather than $1,188. Wegovy is dispensed on the same 28-day cycle, which is why the annual figures here are $5,824 for semaglutide and $7,124 for tirzepatide. Confusingly, four questions earlier on the same page Sesame writes "Month-to-Month Plan: Billed every month at $99 per month". Both sentences are live; only one can be true, and the code sides with 28 days.

No — it is the cheapest listing, not the price. Sesame is a marketplace where clinicians set their own rates, and it says so at the bottom of its own costs FAQ: "Note that providers on Sesame set their own prices, which means that some providers may offer the service at a higher price." That cuts both ways. Being able to read a doctor's reviews and pick them yourself is the best feature Sesame has, and it is meaningfully better than the assign-you-whoever model most of this category runs on. But it means the number in the advert belongs to whichever provider is cheapest today, and the one you actually want to see may not be that provider.

The oral pill, if a provider thinks it suits you. Sesame quotes the Wegovy pill at $149 a month for the 1.5 mg and 4 mg strengths through NovoCare, which with a $99 subscription is $248 all-in — the least expensive branded-drug route on the site. The catch is the same one that runs through everything here: $149 is the low-dose price, and 9 mg and 25 mg are $299. If you have insurance that covers the drug, Sesame quotes copays as low as $25 a month and its providers will file the prior-authorisation paperwork, which is genuinely the cheapest path of all — but that depends entirely on your plan, not on Sesame.

There is no way to check from the site, which is a real gap. Sesame's Terms of Service say the service is "available to individuals who are located in states in which we offer the Service" and then name none of them, and no coverage page or state list exists anywhere else on the site. What Sesame does name states for is lab costs, and even there its two disclosures disagree: the weight-loss FAQ says the subscription does not cover lab work in AZ, HI, ND, NJ, NY, OK, RI, SD or WY, while the "What's included?" panel attached to every medication page names only NJ, NY and RI. Neither is a statement about whether you can be treated. Email support before you pay.

No. The live warning-letter index was queried on August 9, 2026 in three forms — "sesame care" (5 results), "sesamecare" (0) and the deliberately broad "sesame" (47) — with every result returned in full rather than paged, so nothing was hidden by truncation. All 47 were re-checked against the company column and every one is a bakery, food importer, supplement maker or similar business for which sesame is an ingredient, plus one medical-device institute. Sesame, Inc. does not appear. The screen was run with a positive control that returned SkinnyRx's February 2026 letter as expected, so the absence is a finding and not a broken query.

It is gone from the site but still in the code, and the number it left behind is worth knowing about precisely because you might otherwise find it. Sesame's shipped JavaScript still contains a complete compounded-semaglutide product — a landing page, a comparison table claiming "Success by Sesame is just $249 per month, weight loss medication included (with no price markup)", and a "Pre-order Your Compounded Semaglutide Rx" checkout. None of it is reachable: two of the three URLs return 404, the third redirects to the general weight-loss page, and the word "compounded" does not appear once in the rendered text of the live programme page. A $249 all-in price with the drug included would be the best number on this review by a distance. It is not on offer, and it is not counted here.